Fractal and Machine Learning Analyses of MALDI-TOF Mass Spectrometry Data in Glioblastoma
Computational and Structural Biotechnology Journal · 01.03.2026 · 35 (1)
DOI: 10.34133/csbj.0169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Computational and Structural Biotechnology Journal, online erschienen am 04.08.2026. Verfasst von Lucas C Lazari und 7 weiteren Autor:innen. Beteiligte Einrichtung: GlycoProteomics Laboratory, Department of Parasitology, ICB, University of São Paulo, São Paulo, Brazil. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Data preprocessing is a critical step in the analysis of matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS) spectra for machine learning applications, typically involving steps such as spectra trimming, baseline correction, smoothing, transformation, and peak picking or spectral binning. While traditional approaches focus on protein/peptide peaks as features, this study explores a novel method of feature extraction by treating MALDI-TOF spectra as one-dimensional signal array further processed as time-series data. This study investigates the use of computational fractal-based analysis to assess the complexity of MALDI-TOF spectra. Fractal analysis, previously successful in glioblastoma diagnosis using magnetic resonance imaging, was applied here to proteomics data. By treating each MALDI spectrum as a time series and calculating its fractal dimension using various algorithms, machine learning models were trained to differentiate between glioblastoma patients and controls. We demonstrate that fractal dimensions are sufficient to obtain accurate models for glioblastoma diagnosis, despite still underperforming when compared to the traditional feature extraction method. We also show that fractals can be used as support features to increase model performance. This work highlights the potential and limitations of fractal analysis in proteomics, offering a new perspective for disease diagnosis and broadening the available computational tools for data analysis in mass spectrometry.
Autor:innen und Institutionen
- GlycoProteomics Laboratory, Department of Parasitology, ICB, University of São Paulo, São Paulo, Brazil.
- Computational NeuroSurgery (CNS) Lab, Faculty of Medicine, Health and Human Sciences, Macquarie Medical School, Macquarie University, Sydney, NSW, Australia.
- Motor Neuron Disease Research Centre, Macquarie Medical School, Macquarie University, Sydney, NSW, Australia.
- Laboratory of Molecular and Cellular Biology, Lim 15, Department of Neurology, Faculdade de Medicina USP, São Paulo, Brazil.
ORCID-Profile: Ghasem Azemi, Carlo Russo, Livia Rosa-Fernandes, Suely K N Marie
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Lazari, L. C., Azemi, G., Russo, C., Rosa-Fernandes, L., Oba-Shinjo, S. M., Marie, S. K. N., Di Ieva, A., & Palmisano, G. (2026). Fractal and Machine Learning Analyses of MALDI-TOF Mass Spectrometry Data in Glioblastoma. Computational and Structural Biotechnology Journal, 35(1). https://doi.org/10.34133/csbj.0169
Vancouver
Lazari LC, Azemi G, Russo C, Rosa-Fernandes L, Oba-Shinjo SM, Marie SKN, et al. Fractal and Machine Learning Analyses of MALDI-TOF Mass Spectrometry Data in Glioblastoma. Computational and Structural Biotechnology Journal. 2026;35(1). doi:10.34133/csbj.0169
BibTeX
@article{Lazari2026,
author = {Lazari, Lucas C and Azemi, Ghasem and Russo, Carlo and Rosa-Fernandes, Livia and Oba-Shinjo, Sueli M and Marie, Suely K N and Di Ieva, Antonio and Palmisano, Giuseppe},
title = {Fractal and Machine Learning Analyses of MALDI-TOF Mass Spectrometry Data in Glioblastoma},
journal = {Computational and Structural Biotechnology Journal},
year = {2026},
volume = {35},
number = {1},
doi = {10.34133/csbj.0169}
}
EUVIMED